NASDAQ
Actinium Pharmaceuticals, Inc. (ATNM) has a current ratio of 6.20x as of Monday, May 25, 2026. This represents a 38.73% decrease compared to its 12-month average of 10.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.